Celltrion Pharm

068760.KQ

38.84 USD

-0.42

-1.07%

Overview

Last close

38.84 usd

Market cap

1.69B usd

52 week high

69.97 usd

52 week low

30.18 usd

Target price

98.72 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

8.4718

Price/Book Value

5.6801

Enterprise Value

1.76B usd

EV/Revenue

4.7718

EV/EBITDA

33.4759

Key financials

Revenue TTM

199.43M usd

Gross Profit TTM

58.68M usd

EBITDA TTM

31.07M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

538.06M usd

Net debt

89.30M usd

About

Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju-si, South Korea.